{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T08:43:47Z","timestamp":1742978627802,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":86,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811043062"},{"type":"electronic","value":"9789811043079"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-4307-9_17","type":"book-chapter","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T12:14:55Z","timestamp":1507724095000},"page":"307-324","source":"Crossref","is-referenced-by-count":4,"title":["Exercise Training in Pulmonary Hypertension and Right Heart Failure: Insights from Pre-clinical Studies"],"prefix":"10.1007","author":[{"given":"Daniel","family":"Moreira-Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"Rita","family":"Ferreira-Nogueira","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Ana Filipa","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alberto","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Tiago","family":"Henriques-Coelho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"issue":"1","key":"17_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67\u2013119","journal-title":"Eur Heart J"},{"issue":"1","key":"17_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","volume":"115","author":"JJ Ryan","year":"2014","unstructured":"Ryan JJ, Archer SL (2014) The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res 115(1):176\u2013188","journal-title":"Circ Res"},{"issue":"24","key":"17_CR3","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/heartjnl-2012-301992","volume":"98","author":"G Strange","year":"2012","unstructured":"Strange G, Playford D, Stewart S et al (2012) Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 98(24):1805\u20131811","journal-title":"Heart"},{"issue":"5","key":"17_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S2213-2600(16)30041-8","volume":"4","author":"H Wilkens","year":"2016","unstructured":"Wilkens H, Held M (2016) Predictors of long-term survival in pulmonary hypertension. Lancet Respir Med 4(5):338\u2013339","journal-title":"Lancet Respir Med"},{"issue":"17","key":"17_CR5","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/eurheartj\/ehq152","volume":"31","author":"N Galie","year":"2010","unstructured":"Galie N, Palazzini M, Manes A (2010) Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 31(17):2080\u20132086","journal-title":"Eur Heart J"},{"issue":"2","key":"17_CR6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","volume":"142","author":"RL Benza","year":"2012","unstructured":"Benza RL, Miller DP, Barst RJ et al (2012) An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest 142(2):448\u2013456","journal-title":"Chest"},{"key":"17_CR7","unstructured":"Pedersen BK, Saltin B (2015) Exercise as medicine\u00a0\u2013 evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Spor 25(S3):1\u201372"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"i3857","DOI":"10.1136\/bmj.i3857","volume":"354","author":"HH Kyu","year":"2016","unstructured":"Kyu HH, Bachman VF, Alexander LT et al (2016) Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ 354:i3857","journal-title":"BMJ"},{"issue":"2","key":"17_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ Rubin","year":"1997","unstructured":"Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336(2):111\u2013117","journal-title":"N Engl J Med"},{"issue":"6","key":"17_CR10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/CIRCHEARTFAILURE.115.002130","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey A, Garg S, Khunger M et al (2015) Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circulation. Heart failure 8(6):1032\u20131043","journal-title":"Heart failure"},{"key":"17_CR11","first-page":"CD011285","volume":"1","author":"NR Morris","year":"2017","unstructured":"Morris NR, Kermeen FD, Holland AE (2017) Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst Rev 1:CD011285","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"17_CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/674770","volume":"3","author":"G Maarman","year":"2013","unstructured":"Maarman G, Lecour S, Butrous G et al (2013) A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? Pulm Circ 3(4):739\u2013756","journal-title":"Pulm Circ"},{"key":"17_CR13","unstructured":"Colvin KL, Yeager ME (2014) Animal models of pulmonary hypertension: matching disease mechanisms to etiology of the human disease. J Pulm Respir Med 4(4)"},{"issue":"01","key":"17_CR14","doi-asserted-by":"crossref","first-page":"01","DOI":"10.26502\/fccm.9292001","volume":"01","author":"RF-CG Nogueira-Ferreira","year":"2016","unstructured":"Nogueira-Ferreira RF-CG, Ferreira R, Henriques-Coelho T (2016) Animal models for the study of pulmonary hypertension: potential and limitations. Cardiol Cardiovasc Med 01(01):01\u201322","journal-title":"Cardiol Cardiovasc Med"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","volume":"35","author":"R Nogueira-Ferreira","year":"2015","unstructured":"Nogueira-Ferreira R, Vitorino R, Ferreira R et al (2015) Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach. Pulm Pharmacol Ther 35:8\u201316","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"17_CR16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI11144","volume":"106","author":"NF Voelkel","year":"2000","unstructured":"Voelkel NF, Tuder RM (2000) Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 106(6):733\u2013738","journal-title":"J Clin Invest"},{"issue":"3\u20134","key":"17_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ddmod.2011.02.005","volume":"7","author":"L Zhao","year":"2010","unstructured":"Zhao L (2010) Chronic hypoxia-induced pulmonary hypertension in rat: the best animal model for studying pulmonary vasoconstriction and vascular medial hypertrophy. Drug Discov Today Dis Model 7(3\u20134):83\u201388","journal-title":"Drug Discov Today Dis Model"},{"issue":"3","key":"17_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-016-9526-y","volume":"21","author":"MC Veerdonk van de","year":"2016","unstructured":"van de Veerdonk MC, Bogaard HJ, Voelkel NF (2016) The right ventricle and pulmonary hypertension. Heart Fail Rev 21(3):259\u2013271","journal-title":"Heart Fail Rev"},{"issue":"24","key":"17_CR19","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2007.02.055","volume":"49","author":"MJ Haykowsky","year":"2007","unstructured":"Haykowsky MJ, Liang Y, Pechter D et al (2007) A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 49(24):2329\u20132336","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"17_CR20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.107.653576","volume":"117","author":"F Haddad","year":"2008","unstructured":"Haddad F, Hunt SA, Rosenthal DN et al (2008) Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117(11):1436\u20131448","journal-title":"Circulation"},{"issue":"25","key":"17_CR21","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","volume":"62","author":"A Vonk-Noordegraaf","year":"2013","unstructured":"Vonk-Noordegraaf A, Haddad F, Chin KM et al (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62(25):D22\u2013D33","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"17_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1086\/677355","volume":"4","author":"A Gerche La","year":"2014","unstructured":"La Gerche A, Roberts T, Claessen G (2014) The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover conference series). Pulm Circ 4(3):407\u2013416","journal-title":"Pulm Circ"},{"issue":"1","key":"17_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/eurheartj\/ehv337","volume":"37","author":"N Ehlken","year":"2016","unstructured":"Ehlken N, Lichtblau M, Klose H et al (2016) Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J 37(1):35\u201344","journal-title":"Eur Heart J"},{"issue":"1","key":"17_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/japplphysiol.00673.2005","volume":"100","author":"F Favret","year":"2006","unstructured":"Favret F, Henderson KK, Allen J et\u00a0al (2006) Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia. J Appl Physiol 100(1):20\u201325","journal-title":"J Appl Physiol"},{"issue":"1","key":"17_CR25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/cjpp-2012-0261","volume":"91","author":"R Colombo","year":"2013","unstructured":"Colombo R, Siqueira R, Becker CU et al (2013) Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats1. Can J Physiol Pharmacol 91(1):38\u201344","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"17_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/FJC.0000000000000272","volume":"66","author":"R Colombo","year":"2015","unstructured":"Colombo R, Siqueira R, Conzatti A et al (2015) Aerobic exercise promotes a decrease in right ventricle apoptotic proteins in experimental Cor Pulmonale. J Cardiovasc Pharmacol 66(3):246\u2013253","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"17_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00395-015-0514-5","volume":"110","author":"D Moreira-Goncalves","year":"2015","unstructured":"Moreira-Goncalves D, Ferreira R, Fonseca H et al (2015) Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension. Basic Res Cardiol 110(6):57","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"17_CR28","doi-asserted-by":"crossref","first-page":"H421","DOI":"10.1152\/ajpheart.00262.2015","volume":"309","author":"AJ Natali","year":"2015","unstructured":"Natali AJ, Fowler ED, Calaghan SC et al (2015) Voluntary exercise delays heart failure onset in rats with pulmonary artery hypertension. Am J Physiol Heart Circ Physiol 309(3):H421\u2013H424","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"17_CR29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijcard.2015.11.066","volume":"203","author":"R Nogueira-Ferreira","year":"2016","unstructured":"Nogueira-Ferreira R, Moreira-Gon\u00e7alves D, Silva AF et al (2016) Exercise preconditioning prevents MCT-induced right ventricle remodeling through the regulation of TNF superfamily cytokines. Int J Cardiol 203(5):858\u2013866","journal-title":"Int J Cardiol"},{"issue":"2","key":"17_CR30","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1152\/ajpregu.00358.2016","volume":"312","author":"MB Brown","year":"2017","unstructured":"Brown MB, Neves E, Long G et al (2017) High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 312(2):R197\u2013R210","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"17_CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/iep.12166","volume":"97","author":"FL Pacagnelli","year":"2016","unstructured":"Pacagnelli FL, de Almeida Sabela AK, Okoshi K et al (2016) Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline. Int J Exp Pathol 97(3):238\u2013247","journal-title":"Int J Exp Pathol"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vph.2016.06.006","volume":"87","author":"R Colombo","year":"2016","unstructured":"Colombo R, Siqueira R, Conzatti A et al (2016) Exercise training contributes to H2O2\/VEGF signaling in the lung of rats with monocrotaline-induced pulmonary hypertension. Vasc Pharmacol 87:49\u201359","journal-title":"Vasc Pharmacol"},{"issue":"1","key":"17_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.108.829713","volume":"120","author":"ML Handoko","year":"2009","unstructured":"Handoko ML, de Man FS, Happe CM et al (2009) Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation 120(1):42\u201349","journal-title":"Circulation"},{"issue":"2","key":"17_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.acvd.2016.05.008","volume":"110","author":"I Enache","year":"2017","unstructured":"Enache I, Favret F, Doutreleau S et al (2017) Downhill exercise training in monocrotaline-injected rats: effects on echocardiographic and haemodynamic variables and survival. Arch Cardiovasc Dis 110(2):106\u2013115","journal-title":"Arch Cardiovasc Dis"},{"key":"17_CR35","doi-asserted-by":"crossref","unstructured":"Zimmer A, Teixeira RB, Bonetto JH et al (2017) Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension. Mol Cell Biochem:1\u201317","DOI":"10.1007\/s11010-016-2937-1"},{"issue":"3","key":"17_CR36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/JES.0b013e3181aa65fc","volume":"37","author":"U Wisloff","year":"2009","unstructured":"Wisloff U, Ellingsen O, Kemi OJ (2009) High-intensity interval training to maximize cardiac benefits of exercise training? Exerc Sport Sci Rev 37(3):139\u2013146","journal-title":"Exerc Sport Sci Rev"},{"issue":"1","key":"17_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cardiores.2005.03.010","volume":"67","author":"OJ Kemi","year":"2005","unstructured":"Kemi OJ, Haram PM, Loennechen JP et al (2005) Moderate vs. high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovasc Res 67(1):161\u2013172","journal-title":"Cardiovasc Res"},{"issue":"39","key":"17_CR38","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehs338","volume":"35","author":"CD Waring","year":"2014","unstructured":"Waring CD, Vicinanza C, Papalamprou A et al (2014) The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J 35(39):2722\u20132731","journal-title":"Eur Heart J"},{"issue":"3","key":"17_CR39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1152\/jappl.1989.66.3.1250","volume":"66","author":"KJ Rodnick","year":"1989","unstructured":"Rodnick KJ, Reaven GM, Haskell WL et al (1989) Variations in running activity and enzymatic adaptations in voluntary running rats. J Appl Physiol (1985) 66(3):1250\u20131257","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"17_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.33549\/physiolres.931928","volume":"59","author":"Y Wang","year":"2010","unstructured":"Wang Y, Wisloff U, Kemi OJ (2010) Animal models in the study of exercise-induced cardiac hypertrophy. Physiol Res 59(5):633\u2013644","journal-title":"Physiol Res"},{"issue":"24","key":"17_CR41","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","volume":"58","author":"MC Veerdonk van de","year":"2011","unstructured":"van de Veerdonk MC, Kind T, Marcus JT et al (2011) Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 58(24):2511\u20132519","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"17_CR42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9149(01)02159-2","volume":"89","author":"WE Hopkins","year":"2002","unstructured":"Hopkins WE, Waggoner AD (2002) Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 89(1):34\u201338","journal-title":"Am J Cardiol"},{"issue":"21","key":"17_CR43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2009.06.048","volume":"54","author":"CA Warnes","year":"2009","unstructured":"Warnes CA (2009) Adult congenital heart disease: importance of the right ventricle. J Am Coll Cardiol 54(21):1903\u20131910","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"17_CR44","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"WC Members","year":"2009","unstructured":"Members WC, McLaughlin VV, Archer SL et al (2009) ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119(16):2250\u20132294","journal-title":"Circulation"},{"issue":"13","key":"17_CR45","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.107.653584","volume":"117","author":"F Haddad","year":"2008","unstructured":"Haddad F, Doyle R, Murphy DJ et al (2008) Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117(13):1717\u20131731","journal-title":"Circulation"},{"issue":"20","key":"17_CR46","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.109.883843","volume":"120","author":"HJ Bogaard","year":"2009","unstructured":"Bogaard HJ, Natarajan R, Henderson SC et al (2009) Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120(20):1951\u20131960","journal-title":"Circulation"},{"issue":"115","key":"17_CR47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09059180.00007109","volume":"19","author":"ML Handoko","year":"2010","unstructured":"Handoko ML, de Man FS, Allaart CP et al (2010) Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. Eur Respir Rev 19(115):72\u201382","journal-title":"Eur Respir Rev"},{"issue":"2","key":"17_CR48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","volume":"69","author":"A Vonk Noordegraaf","year":"2017","unstructured":"Vonk Noordegraaf A, Westerhof BE, Westerhof N (2017) The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 69(2):236\u2013243","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"17_CR49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/2045-8932.109957","volume":"3","author":"NF Voelkel","year":"2013","unstructured":"Voelkel NF, Gomez-Arroyo J, Abbate A et al (2013) Mechanisms of right heart failure-a work in progress and a plea for failure prevention. Pulm Circ 3(1):137\u2013143","journal-title":"Pulm Circ"},{"issue":"7","key":"17_CR50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/eurjhf\/hfq066","volume":"12","author":"ME Campian","year":"2010","unstructured":"Campian ME, Hardziyenka M, de Bruin K et al (2010) Early inflammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail 12(7):653\u2013658","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"17_CR51","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM, Treacy CM et al (2010) Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122(9):920\u2013927","journal-title":"Circulation"},{"issue":"9","key":"17_CR52","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI119770","volume":"100","author":"BD Lowes","year":"1997","unstructured":"Lowes BD, Minobe W, Abraham WT et al (1997) Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100(9):2315\u20132324","journal-title":"J Clin Invest"},{"issue":"3","key":"17_CR53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.RES.0000085042.89656.C7","volume":"93","author":"H Kogler","year":"2003","unstructured":"Kogler H, Hartmann O, Leineweber K et al (2003) Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. Circ Res 93(3):230\u2013237","journal-title":"Circ Res"},{"issue":"5","key":"17_CR54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00395-009-0017-3","volume":"104","author":"J Correia-Pinto","year":"2009","unstructured":"Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R et al (2009) Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol 104(5):535\u2013545","journal-title":"Basic Res Cardiol"},{"issue":"9","key":"17_CR55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1253\/circj.70.1208","volume":"70","author":"S Usui","year":"2006","unstructured":"Usui S, Yao A, Hatano M et al (2006) Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J 70(9):1208\u20131215","journal-title":"Circ J"},{"issue":"6","key":"17_CR56","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","volume":"296","author":"I Falcao-Pires","year":"2009","unstructured":"Falcao-Pires I, Goncalves N, Henriques-Coelho T et al (2009) Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 296(6):H2007\u2013H2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"17_CR57","doi-asserted-by":"crossref","first-page":"H1038","DOI":"10.1152\/ajpheart.00097.2009","volume":"298","author":"EM Redout","year":"2010","unstructured":"Redout EM, van der Toorn A, Zuidwijk MJ et al (2010) Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. Am J Physiol Heart Circ Physiol 298(3):H1038\u2013H1047","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"17_CR58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4330\/wjc.v2.i10.316","volume":"2","author":"VG Demarco","year":"2010","unstructured":"Demarco VG, Whaley-Connell AT, Sowers JR et al (2010) Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol 2(10):316\u2013324","journal-title":"World J Cardiol"},{"issue":"2","key":"17_CR59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/HJH.0b013e328332bcdb","volume":"28","author":"P Crosswhite","year":"2010","unstructured":"Crosswhite P, Sun Z (2010) Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 28(2):201\u2013212","journal-title":"J Hypertens"},{"issue":"1","key":"17_CR60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1254\/jphs.08322FP","volume":"111","author":"T Daicho","year":"2009","unstructured":"Daicho T, Yagi T, Abe Y et al (2009) Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Sci 111(1):33\u201343","journal-title":"J Pharmacol Sci"},{"issue":"10","key":"17_CR61","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00109-010-0679-1","volume":"88","author":"L Piao","year":"2010","unstructured":"Piao L, Marsboom G, Archer SL (2010) Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med 88(10):1011\u20131020","journal-title":"J Mol Med"},{"key":"17_CR62","first-page":"S755","volume":"18","author":"L Piao","year":"2008","unstructured":"Piao L, Urboniene D, Zhang HJ et al (2008) Abstract 2623: right ventricular hypertrophy in Monocrotaline-induced pulmonary hypertension is associated with impaired oxidative metabolism and action potential prolongation. Circulation 18:S755","journal-title":"Circulation"},{"issue":"11","key":"17_CR63","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jacc.2005.02.065","volume":"45","author":"M Oikawa","year":"2005","unstructured":"Oikawa M, Kagaya Y, Otani H et al (2005) Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 45(11):1849\u20131855","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"17_CR64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.healun.2012.09.025","volume":"32","author":"G Ruiter","year":"2013","unstructured":"Ruiter G, Ying Wong Y, de Man FS et al (2013) Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension. J Heart Lung Transplant 32(2):231\u2013240","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"17_CR65","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.115.016382","volume":"132","author":"F Potus","year":"2015","unstructured":"Potus F, Ruffenach G, Dahou A et al (2015) Downregulation of MicroRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension. Circulation 132(10):932\u2013943","journal-title":"Circulation"},{"key":"17_CR66","doi-asserted-by":"crossref","unstructured":"Rain S, Handoko ML, Trip P et al (2013) Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 128 (18):2016\u20132025, 2011\u20132010","DOI":"10.1161\/CIRCULATIONAHA.113.001873"},{"issue":"6","key":"17_CR67","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1113\/EP085182","volume":"100","author":"MB Brown","year":"2015","unstructured":"Brown MB, Chingombe TJ, Zinn AB et al (2015) Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension. Exp Physiol 100(6):742\u2013754","journal-title":"Exp Physiol"},{"issue":"19","key":"17_CR68","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/01.CIR.98.19.2065","volume":"98","author":"Y Iwanaga","year":"1998","unstructured":"Iwanaga Y, Kihara Y, Hasegawa K et al (1998) Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98(19):2065\u20132073","journal-title":"Circulation"},{"issue":"5","key":"17_CR69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.73.5.887","volume":"73","author":"T Miyauchi","year":"1993","unstructured":"Miyauchi T, Yorikane R, Sakai S et al (1993) Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73(5):887\u2013897","journal-title":"Circ Res"},{"issue":"5","key":"17_CR70","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/0735-1097(95)00568-4","volume":"27","author":"KI Ichikawa","year":"1996","unstructured":"Ichikawa KI, Hidai C, Okuda C et al (1996) Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium. J Am Coll Cardiol 27(5):1286\u20131291","journal-title":"J Am Coll Cardiol"},{"key":"17_CR71","doi-asserted-by":"crossref","unstructured":"Lourenco AP, Roncon-Albuquerque R Jr, Bras-Silva C et al (2006) Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291(4):H1587\u2013H1594","DOI":"10.1152\/ajpheart.01004.2005"},{"issue":"3","key":"17_CR72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hfc.2012.04.005","volume":"8","author":"V Franco","year":"2012","unstructured":"Franco V (2012) Right ventricular remodeling in pulmonary hypertension. Heart Fail Clin 8(3):403\u2013412","journal-title":"Heart Fail Clin"},{"issue":"6","key":"17_CR73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/14728221003752743","volume":"14","author":"I Falcao-Pires","year":"2010","unstructured":"Falcao-Pires I, Ladeiras-Lopes R, Leite-Moreira AF (2010) The apelinergic system: a promising therapeutic target. Expert Opin Ther Targets 14(6):633\u2013645","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"17_CR74","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","volume":"75","author":"EM Redout","year":"2007","unstructured":"Redout EM, Wagner MJ, Zuidwijk MJ et al (2007) Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res 75(4):770\u2013781","journal-title":"Cardiovasc Res"},{"issue":"9","key":"17_CR75","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbabio.2011.04.002","volume":"1807","author":"AI Padrao","year":"2011","unstructured":"Padrao AI, Ferreira RM, Vitorino R et al (2011) OXPHOS susceptibility to oxidative modifications: the role of heart mitochondrial subcellular location. Biochim Biophys Acta 1807(9):1106\u20131113","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"17_CR76","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1152\/japplphysiol.01193.2003","volume":"97","author":"T Hashimoto","year":"2004","unstructured":"Hashimoto T, Kambara N, Nohara R et al (2004) Expression of MHC- \u03b2 and MCT1 in cardiac muscle after exercise training in myocardial-infarcted rats. J Appl Physiol 97(3):843\u2013851","journal-title":"J Appl Physiol"},{"issue":"2","key":"17_CR77","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI118132","volume":"96","author":"TL Orenstein","year":"1995","unstructured":"Orenstein TL, Parker TG, Butany JW et al (1995) Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 96(2):858\u2013866","journal-title":"J Clin Invest"},{"issue":"12","key":"17_CR78","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurjhf\/hfq102","volume":"12","author":"G Galasso","year":"2010","unstructured":"Galasso G, De Rosa R, Piscione F et al (2010) Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure. Eur J Heart Fail 12(12):1290\u20131296","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"17_CR79","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1113\/JP270685","volume":"593","author":"D Moreira-Goncalves","year":"2015","unstructured":"Moreira-Goncalves D, Henriques-Coelho T, Fonseca H et al (2015) Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult. J Physiol 593(17):3885\u20133897","journal-title":"J Physiol"},{"issue":"9","key":"17_CR80","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201412-2271OC","volume":"191","author":"OA Spruijt","year":"2015","unstructured":"Spruijt OA, de Man FS, Groepenhoff H et al (2015) The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med 191(9):1050\u20131057","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"17_CR81","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/jappl.2001.91.3.1283","volume":"91","author":"F Favret","year":"2001","unstructured":"Favret F, Henderson KK, Clancy RL et al (2001) Exercise training alters the effect of chronic hypoxia on myocardial adrenergic and muscarinic receptor number. J Appl Physiol (1985) 91(3):1283\u20131288","journal-title":"J Appl Physiol (1985)"},{"issue":"25","key":"17_CR82","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","volume":"62","author":"RM Tuder","year":"2013","unstructured":"Tuder RM, Archer SL, Dorfmuller P et al (2013) Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 62(25):D4\u2013D12","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"17_CR83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00109-013-0998-0","volume":"91","author":"LA Shimoda","year":"2013","unstructured":"Shimoda LA, Laurie SS (2013) Vascular remodeling in pulmonary hypertension. J Mol Med (Berl) 91(3):297\u2013309","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"17_CR84","doi-asserted-by":"crossref","first-page":"L986","DOI":"10.1152\/ajplung.00275.2013","volume":"306","author":"N Weissmann","year":"2014","unstructured":"Weissmann N, Peters DM, Klopping C et al (2014) Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice. Am J Physiol Lung Cell Mol Physiol 306(11):L986\u2013L995","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1\u20133","key":"17_CR85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2005.10.013","volume":"527","author":"L Goret","year":"2005","unstructured":"Goret L, Reboul C, Tanguy S et al (2005) Training does not affect the alteration in pulmonary artery vasoreactivity in pulmonary hypertensive rats. Eur J Pharmacol 527(1\u20133):121\u2013128","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"17_CR86","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1440-1681.2008.04936.x","volume":"35","author":"MP Souza-Rabbo","year":"2008","unstructured":"Souza-Rabbo MP, Silva LFF, Auzani JAS et al (2008) Effects of a chronic exercise training protocol on oxidative stress and right ventricular hypertrophy in monocrotaline-treated rats. Clin Exp Pharmacol Physiol 35(8):944\u2013948","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Advances in Experimental Medicine and Biology","Exercise for Cardiovascular Disease Prevention and Treatment"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-4307-9_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T07:45:51Z","timestamp":1659599151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-4307-9_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811043062","9789811043079"],"references-count":86,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-4307-9_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2017]]}}}